BioSpace News Archive

Taglich Brothers, Inc. announces that it has initiated coverage of Ocean Biomedical, Inc.

Lyndra Therapeutics, a clinical-stage biopharmaceutical company working to make daily pills a thing of the past, today announced it will present a poster on the results of a simulation-based predictive modeling study comparing the Positive and Negative Syndrome Scale (PANSS) scores produced by oral weekly risperidone (LYN-005) and oral daily risperidone at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting.

Applying its leadership in biopharma filtration technology, 3M announced it will invest $146 million dollars to expand its capabilities to further support biotech manufacturing, a fast-growing area of health care which is bringing breakthrough therapies to patients.

According to our new research study on “Anticoagulant Reversal Drugs Market to 2027 – Global Analysis and Forecast – by Product and Distribution Channel,” the Anticoagulant Reversal Drugs Market was valued at US$ 922.55 million in 2019 and is projected to reach US$ 2,276.54 million by 2027;

According to our new research study on “Cell Therapy Market to 2027 – Global Analysis and Forecast – by Therapy Type, Product, Technology, Application and End User,” the Cell Therapy Market was valued at US$ 7,260.50 million in 2019 and is projected to reach US$ 12,563.23 million by 2027;

According to our new research study on “Gastroparesis Market to 2027 – Global Analysis and Forecast – by Gastroparesis Type, Drug Class Type, and Distribution Channel,” the Gastroparesis Market was valued at US$ 4,338.61 million in 2019 and is projected to reach US$ 6,025.11 million by 2027;

According to our new research study on “Narcolepsy Market to 2027 – Global Analysis and Forecast – by Type, Product, and Distribution Channel,” the Narcolepsy Market Size was valued at US$ 2,202.1 million in 2019 and is projected to reach US$ 4,537.9 million by 2027;

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) announces that it has released Q1 2023 results.

Valve Medical is pleased to announce today the successful First-in-Human (FIH) implantation of their advanced Transcatheter Aortic Valve Replacement (TAVR) system in Israel, introducing a revolutionary advancement in Structural Heart procedures with the world’s first modular valve.

Responding to increased healthcare provider demand for digital and scalable inventory management solutions, Medline has enhanced its supply chain optimization portfolio with a new partnership with IDENTI Medical.